23.01.2017
Resignation of Barthold Piening, Chief Operations Officer
Barthold Piening, Chief Operations Officer and Member of the Executive Committee, has decided to leave Acino by mid of this...
Acino
News
30.11.2016
Acino closes the deal to divest its patch business to Luye Pharma Group Ltd.
On November 30, 2016, Acino International AG and Acino Pharma AG (together “Acino”) closed the deal with Luye Pharma Group...
01.11.2016
Acino closes the deal to acquire packaging plant in Põlva
Following the announcement of Acino and Takeda that Acino will acquire Takeda’s manufacturing site in Põlva, Estonia, the closing of...
31.10.2016
Acino launches its new corporate brand identity
Acino is very pleased to launch today its new corporate brand identity and its new website under the URL www.acino.swiss.The new...
25.07.2016
Acino divests its patch business to Luye Pharma Group Ltd.
Today Acino International AG and Acino Pharma AG (together “Acino”) have signed a definitive agreement with Luye Pharma Group Ltd....
13.07.2016
Acino to acquire Takeda’s manufacturing plant in Põlva, Estonia
Acino and Takeda announced today that Acino will acquire Takeda’s manufacturing site in Põlva, Estonia.The packaging site in Estonia is...
28.06.2016
Acino acquires the Middle East and North Africa (MENA) operations and product rights from Norgine B.V.
Acino today announced that it has completed the acquisition of the MENA operations and product rights for MOVICOL®, MOVIPREP®, KLEAN-PREP® and...
07.10.2015
Acino continues expanding its emerging markets business by acquiring Pharma Start
Effective October 1, 2015, Acino Pharma, an international pharmaceutical company headquartered in Switzerland, acquires Pharma Start, the 9th largest local...
04.09.2015
Acino launches the first generic Rivastigmine patch in the USA
Acino’s rivastigmine patch is the first generic alternative to the originator product making the medical treatment of Alzheimer’s more affordable...